Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shock.
Zeymer U, Lober C, Richter S, Olivier CB, Huber K, Haring B, Schwimmbeck P, Andrassy M, Akin I, Cuneo A, Desch S, Thiele H, Geisler T. Zeymer U, et al. Among authors: olivier cb. Eur Heart J Acute Cardiovasc Care. 2023 Jul 7;12(7):462-463. doi: 10.1093/ehjacc/zuad041. Eur Heart J Acute Cardiovasc Care. 2023. PMID: 37042356 No abstract available.
The German CaRe high registry for familial hypercholesterolemia - Sex differences, treatment strategies, and target value attainment.
März W, Schmidt N, An Haack I, Dressel A, Grammer TB, Kleber ME, Baessler A, Beil FU, Gouni-Berthold I, Julius U, Kassner U, Katzmann JL, Klose G, König C, Koenig W, Koschker AC, Laufs U, Merkel M, Otte B, Parhofer KG, Hengstenberg W, Schunkert H, Stach-Jablonski K, Steinhagen-Thiessen E, Olivier CB, Hahmann H, Krzossok S, Vogt A, Müller-Wieland D, Schatz U. März W, et al. Among authors: olivier cb. Atheroscler Plus. 2023 Jun 12;53:6-15. doi: 10.1016/j.athplu.2023.06.001. eCollection 2023 Sep. Atheroscler Plus. 2023. PMID: 37434912 Free PMC article. Review.
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study.
Gjermeni D, Anfang V, Vetter H, Szabó S, Hesselbarth D, Gauchel N, Siegel PM, Kaier K, Kille A, Franke K, Leggewie S, Trenk D, Duerschmied D, Bode C, Westermann D, Olivier CB. Gjermeni D, et al. Among authors: olivier cb. J Thromb Thrombolysis. 2024 Mar;57(3):361-369. doi: 10.1007/s11239-023-02937-0. Epub 2024 Feb 12. J Thromb Thrombolysis. 2024. PMID: 38347374 Free PMC article.
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Barco S, Voci D, Held U, Sebastian T, Bingisser R, Colucci G, Duerschmied D, Frenk A, Gerber B, Götschi A, Konstantinides SV, Mach F, Robert-Ebadi H, Rosemann T, Simon NR, Spechbach H, Spirk D, Stortecky S, Vaisnora L, Righini M, Kucher N; OVID investigators. Barco S, et al. Lancet Haematol. 2022 Aug;9(8):e585-e593. doi: 10.1016/S2352-3026(22)00175-2. Epub 2022 Jun 30. Lancet Haematol. 2022. PMID: 35779558 Free PMC article. Clinical Trial.
38 results